Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03072043
Title Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Weill Medical College of Cornell University New York New York 10065 United States Details
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 United States Details
University of Texas M.D. Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field